HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K Shirasuna Selected Research

Odontogenic Cysts (Keratocyst)

5/2009Expression of keratinocyte growth factor and its receptor in odontogenic keratocysts.
2/2007Signaling pathways regulating IL-1alpha-induced COX-2 expression.
10/2005Effects of positive pressure in odontogenic keratocysts.
1/2002Interleukin-1alpha enhances type I collagen-induced activation of matrix metalloproteinase-2 in odontogenic keratocyst fibroblasts.
8/2001Discrimination of ameloblastomas from odontogenic keratocysts by cytokine levels and gelatinase species of the intracystic fluids.
6/2000Interleukin-1alpha-dependent regulation of matrix metalloproteinase-9(MMP-9) secretion and activation in the epithelial cells of odontogenic jaw cysts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


K Shirasuna Research Topics

Disease

6Odontogenic Cysts (Keratocyst)
05/2009 - 06/2000
6Neoplasms (Cancer)
07/2006 - 11/2000
2Squamous Cell Carcinoma of Head and Neck
07/2006 - 09/2005
2Carcinoma (Carcinomatosis)
01/2001 - 11/2000
1Infections
10/2012
1Inflammation (Inflammations)
08/2012
1Mouth Neoplasms (Oral Cancer)
09/2005
1Stomatitis
09/2005
1Oral Lichen Planus
05/2003
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2001
1Ameloblastoma
08/2001
1Hypoxia (Hypoxemia)
01/2001
1Radicular Cyst
06/2000
1Dentigerous Cyst
06/2000
1Cysts
06/2000

Drug/Important Bio-Agent (IBA)

3Interleukin-1alpha (Interleukin 1 alpha)IBA
10/2005 - 06/2000
2NF-kappa B (NF-kB)IBA
02/2007 - 12/2001
2AntigensIBA
07/2006 - 05/2003
2Proteins (Proteins, Gene)FDA Link
10/2005 - 01/2001
2CytokinesIBA
10/2005 - 08/2001
2Messenger RNA (mRNA)IBA
10/2005 - 01/2001
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2001 - 11/2000
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2001 - 11/2000
1LipopolysaccharidesIBA
10/2012
1Peptidoglycan (Murein)IBA
10/2012
1Endothelin-1 (Endothelin 1)IBA
08/2012
1Angiotensin IIIBA
08/2012
1Nitric Oxide (Nitrogen Monoxide)FDA Link
08/2012
1Fibroblast Growth Factor 7FDA Link
05/2009
1ProstaglandinsIBA
02/2007
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
02/2007
1Prostaglandins EIBA
02/2007
1DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
07/2006
1Dinoprostone (PGE2)FDA Link
10/2005
1Matrix Metalloproteinases (MMPs)IBA
10/2005
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
05/2003
1progelatinaseIBA
01/2002
1Collagen Type I (Type I Collagen)IBA
01/2002
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
01/2002
1Matrix Metalloproteinase 14 (MT1-MMP)IBA
01/2002
1I-kappa B KinaseIBA
12/2001
1Phosphotransferases (Kinase)IBA
12/2001
1GelatinasesIBA
08/2001
1InterleukinsIBA
08/2001
1Interleukin-6 (Interleukin 6)IBA
08/2001
1GelatinIBA
08/2001
1Immunoglobulin G (IgG)IBA
01/2001
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
01/2001
1Thromboplastin (Tissue Factor)IBA
11/2000
1Transforming Growth Factor beta1 (TGF beta 1)IBA
11/2000
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2000
1Liposomes (Liposome)IBA
11/2000
1prostromelysinIBA
06/2000
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
06/2000
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
06/2000
1pro-matrix metalloproteinase 9IBA
06/2000

Therapy/Procedure

1Chemoradiotherapy
09/2005
1Drug Therapy (Chemotherapy)
09/2005
1Radiotherapy
09/2005